يحاول ذهب - حر
Novo moves HC to restrain Sun Pharma
December 10, 2025
|Mint Hyderabad
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
The Danish drugmaker on Tuesday moved the Delhi High Court, seeking to restrain domestic giant Sun Pharmaceutical Industries from launching its generic version of semaglutide, a widely prescribed drug for diabetes and weight loss.
The matter was heard briefly by a bench headed by justice Tejas Karia, who transferred the case to the bench already hearing Novo's parallel litigation against Dr. Reddy’s Laboratories and Natco Pharma concerning the same patent.
The plea is likely to be taken up today before justice Manmeet Pritam Singh Arora, who last week allowed Dr. Reddy's Laboratories to export semaglutide to non-patent nations.
هذه القصة من طبعة December 10, 2025 من Mint Hyderabad.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Hyderabad
Mint Hyderabad
Oil shock shudders need not scare equity holders
The Iran war has made oil spike and equities slide. While RBI could steady the rupee with its dollar stash, investors should focus on what stocks are worth instead of capital gains
2 mins
March 10, 2026
Mint Hyderabad
LPG curbs tightened as oil roars past $100
Supply constraints likely; G-7 may open strategic crude reserves
1 min
March 10, 2026
Mint Hyderabad
WC win makes players more bankable
India's ICC Men's T20 World Cup victory on Sunday—its second in a row after the 2024 triumph—is already shaping conversations around endorsements for cricketers, with top performers attracting early queries.
1 mins
March 10, 2026
Mint Hyderabad
Capital gains exemption on shares: what NRIs should know
I am an NRI living in Australia. I filed my FY25 tax return to claim TDS refund and gave my NRE account details, but the refund has failed. Now, can I change the refund account to my NRO account, and request the refund again?
1 min
March 10, 2026
Mint Hyderabad
GM's aftermarket brand back in India
American auto major General Motors’ (GM) aftermarket automotive products brand ACDelco has reentered the Indian market on Monday through a licensing pact with Assurance Intl Ltd.
1 min
March 10, 2026
Mint Hyderabad
Ather eyes big distribution growth, to add 400 stores
Company targets 1,100 stores by March 2027, which translates to over one store opening a day
3 mins
March 10, 2026
Mint Hyderabad
360 One Asset closes $400-mn private credit fund
60 ONE Asset has closed its fifth private credit fund with a corpus of $400 million (₹3,500 crore) and will offer structured and innovative credit solutions to high-quality Indian companies, the investment firm said in a statement on Monday.
1 min
March 10, 2026
Mint Hyderabad
Arcil appoints Phanindranath Kakarla as CEO and MD
Asset Reconstruction Company (India) Ltd (Arcil) on Monday said it has appointed Phanindranath Kakarla as its chief executive officer (CEO) and managing director (MD) with effect from 8 March, succeeding Pallav Mohapatra, the company said in a release.
1 min
March 10, 2026
Mint Hyderabad
War raises alarm for India Inc
The conflict presents a trifecta of risks for Indian companies—soaring crude prices, supply-chain disruptions and a depreciating rupee, experts say
1 min
March 10, 2026
Mint Hyderabad
India urges dialogue for West Asia peace
India on Monday advocated deescalation of tensions in West Asia and called for dialogue and diplomacy to resolve all underlying issues, as it put the safety of around one crore Indians in the region as its top priority, along with securing energy security and trade.
1 min
March 10, 2026
Listen
Translate
Change font size